The registration, importation and distribution of all heartburn medication containing ranitidine has been suspended in the UAE.
According to the Ministry of Health and Prevention (MoHAP), a circular was issued to health facilities and practitioners informing them about the move.
The decision is based on the recommendations of the US Food and Drug Administration (FDA) and other regulatory bodies regarding a possible contamination of the medicine with an impurity which is classified as potentially carcinogenic.
The Ministry says those wishing to stop taking medicine with ranitidine should consult a healthcare professional for a replacement.

UAE announces $30 million emergency aid package for Sudan
7 arrested in Sharjah for using fake apps to steal money
H.H. Sheikh Mohammed hails Morocco's 'fighting spirit' in World Cup run
UAE aid convoys enter Gaza with food and shelter supplies
UAE leaders congratulate US President on Independence Day
Dubai private schools to offer life skills to shape future-ready students
Warning issued after 25 injured in 4 vehicle collision on Jebel Ali Road
H.H. Sheikh Mohammed applauds Egypt's 'heroic' World Cup run
